Hubei Cancer Hospital
65
18
21
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.5%
1 terminated/withdrawn out of 65 trials
92.3%
+5.8% vs industry average
9%
6 trials in Phase 3/4
0%
0 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (65)
PRL3-Zumab in Patients With Advanced Solid Tumors
Role: collaborator
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
Role: collaborator
A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy
Role: collaborator
DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes
Role: lead
Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea
Role: lead
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Role: lead
A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.
Role: lead
Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy
Role: lead
Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1
Role: collaborator
Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension
Role: collaborator
SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
Role: lead
Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.
Role: lead
Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer
Role: collaborator
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
Role: collaborator
Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery
Role: lead
Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction
Role: lead
Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma
Role: collaborator
Orlistat Overcoming Third-generation EGFR-TKI Resistance
Role: collaborator
Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
Role: lead
Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers
Role: collaborator